Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mayne Pharma (MYX AU)
Watchlist
225
Analysis
Health Care
•
Australia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Nongfu Spring
•
20 Feb 2022 04:23
Index Rebalance & ETF Flow Recap: HSI, HSCEI, HSTECH, HSCI, S&P/ASX, SET50, LIC, SBI Sumishin, Crown
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
711 Views
Share
bullish
•
Centuria Capital
•
05 Jul 2021 12:51
ASX200 Sep21 Index Rebalance Preview: Large Impact Names
We see 3 potential changes to the ASX200 at the Sep rebalance with CNI, PNI and SLK being included and NXL, NRW and GEM being deleted. Passive...
Brian Freitas
Follow
643 Views
Share
bullish
•
Allkem Ltd
•
28 May 2021 05:50
ASX200 Index Rebalance Preview: Gold Miners Shining
We see 3 potential changes to the ASX200 in the June review. All inclusions/exclusions have over 3 days of ADV to trade from passive funds. Short...
Brian Freitas
Follow
559 Views
Share
bullish
•
Codan
•
01 Mar 2021 06:18
ASX200 Index Rebalance Preview: Three Potential Changes & Some Close Names
We see three potential changes to the ASX200 in the March review while there are another two close adds/deletes. High short interest on the...
Brian Freitas
Follow
627 Views
Share
bullish
•
Centuria Industrial REIT
•
12 Jun 2020 11:25
ASX200 Index Review - A Handful of Changes
S&P Dow Jones Indices announced changes to the S&P/ASX 200 (AS51 INDEX) today. The changes are effective at the open of trading on 22 June...
Brian Freitas
Follow
706 Views
Share
First
Previous
36
37
38
39
40
41
42
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x